Contract W81K0223P0125
Quidelortho Sales Company, Llc · Department Of Defense · September 22, 2023
Quidelortho Sales Company, Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on September 22, 2023 for $506,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Joint Base Lewis Mcchord, WA. It was awarded under full and open competition. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 30, 2025.
Contract details
- PIID
- W81K0223P0125
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Joint Base Lewis Mcchord, WA
- First action
- September 22, 2023
- Latest action
- December 30, 2025
Description
STATEMENT OF WORK IN VITRO DIAGNOSTIC REAGENTS AND TEST KITSMADIGAN ARMY MEDICAL CENTER1. SCOPE OF WORK: THIS IS A SUPPLY ONLY CONTRACT. THE CONTRACTOR WILL SHIP ALL REAGENTS AND TEST KITS VIA THIRD P
Modification timeline
-
December 30, 2025Mod P00007STATEMENT OF WORK IN VITRO DIAGNOSTIC REAGENTS AND TEST KITSMADIGAN ARMY MEDICAL CENTER1. SCOPE OF WORK: THIS IS A SUPPLY ONLY CONTRACT. THE CONTRACTOR WILL SHI$168.8K
-
November 20, 2025Mod P00006STATEMENT OF WORK IN VITRO DIAGNOSTIC REAGENTS AND TEST KITSMADIGAN ARMY MEDICAL CENTER1. SCOPE OF WORK: THIS IS A SUPPLY ONLY CONTRACT. THE CONTRACTOR WILL SHI$0
-
June 10, 2025Mod P00005STATEMENT OF WORK IN VITRO DIAGNOSTIC REAGENTS AND TEST KITSMADIGAN ARMY MEDICAL CENTER1. SCOPE OF WORK: THIS IS A SUPPLY ONLY CONTRACT. THE CONTRACTOR WILL SHI$0
-
February 20, 2025Mod P00004MTS A/B/D MONO & REVERSE GRP CARD - DE-OBLIGATE FY 24 FUNDING (CLINS 0001, 0007, 0015) AND UPDATE PRODUCT CODE CLIN(S) 1006, 2006, 3006.$-653
-
October 29, 2024Mod P00003MTS A/B/D MONO & REVERSE GRP CARD - OBLIGATE FUNDING$168.8K
-
April 22, 2024Mod P00002MODIFICATION - EXERCISE OPTION (1) MTS A/B/D MONO & REVERSE GRP CARD$0
-
October 19, 2023Mod P00001MODIFICATION - FUNDING BASE YEAR - MTS A/B/D MONO & REVERSE GRP CARD$168.8K
-
September 22, 2023Base awardREAGENTS & CONSUMABLES$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81K0223P0125?
Contract W81K0223P0125 is a federal contract awarded to Quidelortho Sales Company, Llc by Department Of Defense on September 22, 2023 for $506,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 7 times since the base award.
Who won contract W81K0223P0125?
Quidelortho Sales Company, Llc won contract W81K0223P0125 from Department Of Defense.
How much is contract W81K0223P0125 worth?
Contract W81K0223P0125 has obligated $506,000 to date, with a total potential value of $675,000 if all options are exercised.